Mijatović et al., 2014 - Google Patents
Study of the anticancer properties of methyl-and phenyl-substituted carbon-and silicon-bridged ansa-titanocene complexesMijatović et al., 2014
View PDF- Document ID
- 8611001169347861184
- Author
- Mijatović S
- Bulatović M
- Mojić M
- Stošić-Grujičić S
- Miljković D
- Maksimović-Ivanić D
- Gomez-Ruiz S
- Pinkas J
- Horáček M
- Kaluđerović G
- Publication year
- Publication venue
- Journal of Organometallic Chemistry
External Links
Snippet
The previously known complexes [Ti {(Me 2 CMe 2 C)(η 5-C 5 H 4) 2} Cl 2](1),[Ti {Me 2 C (η 5-C 5 H 4) 2} Cl 2](2),[Ti {Me 2 Si (η 5-C 5 H 4) 2} Cl 2](4),[Ti {MePhSi (η 5-C 5 H 4) 2} Cl 2](5) and [Ti {MePhSi (η 5-C 5 Me 4) 2} Cl 2](6) have been prepared following reported …
- 230000001093 anti-cancer 0 title abstract description 7
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F17/00—Metallocenes
- C07F17/02—Metallocenes of metals of Groups 8, 9 or 10 of the Periodic System
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P-C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hearn et al. | Organometallic iridium (III) anticancer complexes with new mechanisms of action: NCI-60 screening, mitochondrial targeting, and apoptosis | |
| Subarkhan et al. | Ruthenium (II) arene complexes containing benzhydrazone ligands: synthesis, structure and antiproliferative activity | |
| Mendes et al. | Gallium (III) complexes of 2-pyridineformamide thiosemicarbazones: cytotoxic activity against malignant glioblastoma | |
| Kurzwernhart et al. | Structure–activity relationships of targeted RuII (η6-p-Cymene) anticancer complexes with flavonol-derived ligands | |
| Oramas-Royo et al. | Synthesis and cytotoxic activity of metallic complexes of lawsone | |
| Chellan et al. | Synthesis and evaluation of new polynuclear organometallic Ru (II), Rh (III) and Ir (III) pyridyl ester complexes as in vitro antiparasitic and antitumor agents | |
| Ferreira et al. | Synthesis and characterization of new organometallic benzo [b] thiophene derivatives with potential antitumor properties | |
| Miklášová et al. | Antiproliferative effect of novel platinum (II) and palladium (II) complexes on hepatic tumor stem cells in vitro | |
| Margiotta et al. | Platinum (II) complexes with bioactive carrier ligands having high affinity for the translocator protein | |
| CN103848747B (en) | Curcumin analogue, its medicinal salt and its preparation and application | |
| Adams et al. | Synthesis, characterization and antiplasmodial evaluation of cyclopalladated thiosemicarbazone complexes | |
| Sathiyaraj et al. | Synthesis, characterization, DNA interaction and in vitro cytotoxicity activities of ruthenium (II) Schiff base complexes | |
| Tabrizi et al. | Ruthenium (II) p-cymene complexes of naphthoquinone derivatives as antitumor agents: A structure− activity relationship study | |
| Albert et al. | Neutral and ionic platinum compounds containing a cyclometallated chiral primary amine: synthesis, antitumor activity, DNA interaction and topoisomerase I–cathepsin B inhibition | |
| Mohan et al. | Synthesis, structure and anticancer activity of (η6-benzene) ruthenium (II) complexes containing aroylhydrazone ligands | |
| Patel et al. | Design, synthesis, characterization and anticancer activity evaluation of deoxycholic acid-chalcone conjugates | |
| Huang et al. | Platinum (II) complexes with mono-aminophosphonate ester targeting group that induce apoptosis through G1 cell-cycle arrest: synthesis, crystal structure and antitumour activity | |
| Ahmad et al. | New ferrocene modified lawsone Mannich bases with anti-proliferative activity against tumor cells | |
| Kocsis et al. | Synthesis, structure and in vitro cytostatic activity of ferrocene—Cinchona hybrids | |
| Subran et al. | Amberlite IR-120 (H)-mediated “on water” synthesis of novel anticancer ruthenium (II)–p-cymene 2-pyridinylbenzothiazole (BTZ), 2-pyridinylbenzoxazole (BOZ) & 2-pyridinylbenzimidazole (BIZ) scaffolds | |
| Albert et al. | Cyclopalladated primary amines: A preliminary study of antiproliferative activity through apoptosis induction | |
| Starha et al. | Half-sandwich Ir (III) complex of N 1-pyridyl-7-azaindole exceeds cytotoxicity of cisplatin at various human cancer cells and 3D multicellular tumor spheroids | |
| Mijatović et al. | Study of the anticancer properties of methyl-and phenyl-substituted carbon-and silicon-bridged ansa-titanocene complexes | |
| Vessières et al. | Proliferative and anti-proliferative effects of titanium-and iron-based metallocene anti-cancer drugs | |
| Moradell et al. | Platinum complexes of diaminocarboxylic acids and their ethyl ester derivatives: the effect of the chelate ring size on antitumor activity and interactions with GMP and DNA |